Company intelligence / Profile preview
Teon Therapeutics
Redwood City, California, United Statesteontherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Teon Therapeutics develops oral small molecule drugs targeting untapped metabolic signaling pathways—especially GPCRs—to restore anti-tumor immunity. Their lead candidate, TT‑702, an A2BR antagonist, has shown preclinical superiority over competitors and was expected to enter Phase 1b trials in oncology. The company’s leadership team has deep expertise in adenosine biology and oncology drug development. The pipeline includes first-in-class candidates for difficult-to-treat cancers with a focus on improving outcomes for patients underserved by current immunotherapies.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
No major partnerships publicly disclosed; open to collaborations to advance their mission.
Beyond the preview
Go deeper on Teon Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Teon Therapeutics.